Frailty in lung cancer patients
Part of Cancer, Lungs & breathing clinical trials.
This study uses a simple questionnaire to understand how frailty affects people living with lung cancer. It helps doctors learn more about your overall health and how to better support you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed lung cancer diagnosis from a biopsy or cell sample.
- You must be 18 years or older.
- You should be able to fill out a questionnaire on your own or with help from the study team.
- You cannot have serious organ failure (heart, lung, kidney) or dementia, mental illness, or severe vision/hearing/speech problems.
- You cannot be taking part in any other research studies at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why some seriously ill adults become frail. It involves imaging and other tests to help doctors better understand and care for patients with serious conditions.
This study looks at people with COPD or ILD who also show signs of frailty. It aims to understand how frailty and muscle loss (sarcopenia) affect their care and use of medical resources over time.
This study looks at whether frailty (how weak or vulnerable someone is) changes the risk of heart-related events and death in people with COPD. It may help doctors better predict who is at higher risk and tailor care.
This study looks at how frailty (weakness and tiredness) affects the daily life and well-being of women 60 or older who have just been diagnosed with a common type of breast cancer. The goal is to understand their needs better so doctors can provide more supportive care.
This study looks at how frailty (a state of being more vulnerable to health problems) affects people with scarring lung diseases. It aims to understand if frailty can help predict how the disease will progress and how treatments might be adjusted.
This study looks at how frailty (physical weakness and loss of strength) affects older men who have been diagnosed with prostate cancer. Researchers want to understand which men are at higher risk and how this might guide better treatment decisions.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.